Indexes of von willebrand factor as biomarkers of aortic stenosis severity (from the biomarkers of aortic stenosis severity [BASS] study)

American Journal of Cardiology

Volumn 111, Issue 3, 2013, Pages 374-381

  Blackshear, Joseph L ^a   Wysokinska, Ewa M ^b   Safford, Robert E ^a   Thomas, Colleen S ^a   Stark, Mark E ^a   Shapiro, Brian P ^a   Ung, Steven ^a   Johns, Gretchen S ^a   Chen, Dong ^b  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; BRAIN NATRIURETIC PEPTIDE; COLLAGEN; VON WILLEBRAND FACTOR;

AGED; AORTA STENOSIS; AORTA VALVE REPLACEMENT; AREA UNDER THE CURVE; ARTICLE; BLOOD CLOTTING PARAMETERS; DISEASE SEVERITY; FEMALE; HUMAN; LATEX AGGLUTINATION TEST; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; THROMBOCYTE FUNCTION ANALYZER;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; BIOLOGICAL MARKERS; BLOOD COAGULATION TESTS; ECHOCARDIOGRAPHY; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS; HUMANS; MALE; SEVERITY OF ILLNESS INDEX; VON WILLEBRAND FACTOR;

EID: 84872349140     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.10.015     Document Type: Article

References (30)

1. H. Baumgartner, T. Stefenelli, J. Niederberger, H. Schima, and G. Maurer "Overestimation" of catheter gradients by Doppler ultrasound in patients with aortic stenosis: a predictable manifestation of pressure recovery J Am Coll Cardiol 33 1999 1655 1661
2. J. Minners, M. Allgeier, C. Gohlke-Baerwolf, R.P. Kienzle, F.J. Neumann, and N. Jander Inconsistencies of echocardiographic criteria for the grading of aortic valve stenosis Eur Heart J 29 2008 1043 1048
3. E. Bahlmann, D. Cramariuc, E. Gerdts, C. Gohlke-Baerwolf, C.A. Nienaber, E. Eriksen, K. Wachtell, J. Chambers, K.H. Kuck, and S. Ray Impact of pressure recovery on echocardiographic assessment of asymptomatic aortic stenosis: a SEAS substudy JACC Cardiovasc Imaging 3 2010 555 562
4. C.E. Kurtz, and C.M. Otto Aortic stenosis: clinical aspects of diagnosis and management, with 10 illustrative case reports from a 25-year experience Medicine (Baltimore) 89 2010 349 379
5. A. Vahanian, and C.M. Otto Risk stratification of patients with aortic stenosis Eur Heart J 31 2010 416 423
6. E. Aikawa, and C.M. Otto Look more closely at the valve: imaging calcific aortic valve disease Circulation 125 2012 9 11
7. N. Jander, J. Minners, I. Holme, E. Gerdts, K. Boman, P. Brudi, J.B. Chambers, K. Egstrup, Y.A. Kesaniemi, W. Malbecq, C.A. Nienaber, S. Ray, A. Rossebo, T.R. Pedersen, T. Skjaerpe, R. Willenheimer, K. Wachtell, F.J. Neumann, and C. Gohlke-Barwolf Outcome of patients with low-gradient "severe" aortic stenosis and preserved ejection fraction Circulation 123 2011 887 895
8. P. Lancellotti, J. Magne, E. Donal, L. Davin, K. O'Connor, M. Rosca, C. Szymanski, B. Cosyns, and L.A. Pierard Clinical outcome in asymptomatic severe aortic stenosis: insights from the new proposed aortic stenosis grading classification J Am Coll Cardiol 59 2012 235 243
9. C.D. Steadman, S. Ray, L.L. Ng, and G.P. McCann Natriuretic peptides in common valvular heart disease J Am Coll Cardiol 55 2010 2034 2048
10. A. Vincentelli, S. Susen, T. Le Tourneau, I. Six, O. Fabre, F. Juthier, A. Bauters, C. Decoene, J. Goudemand, A. Prat, and B. Jude Acquired von Willebrand syndrome in aortic stenosis N Engl J Med 349 2003 343 349
11. K. Yoshida, S. Tobe, M. Kawata, and M. Yamaguchi Acquired and reversible von Willebrand disease with high shear stress aortic valve stenosis Ann Thorac Surg 81 2006 490 494
12. C. Sucker, P. Feindt, R.B. Zotz, M. Stockschlaeder, and R.E. Scharf Functional von Willebrand factor assays are not predictive for the absence of highest-molecular weight von Willebrand factor multimers in patients with aortic-valve stenosis Thromb Haemost 94 2005 465 466
13. A. Casonato, S. Sponga, E. Pontara, M.G. Cattini, C. Basso, G. Thiene, G. Cella, V. Daidone, G. Gerosa, and A. Pagnan Von Willebrand factor abnormalities in aortic valve stenosis: pathophysiology and impact on bleeding Thromb Haemost 106 2011 58 66
14. C. Solomon, U. Budde, S. Schneppenheim, E. Czaja, C. Hagl, H. Schoechl, M. von Depka, and N. Rahe-Meyer Acquired type 2A von Willebrand syndrome caused by aortic valve disease corrects during valve surgery Br J Anaesth 106 2011 494 500
15. T. Le Tourneau, S. Susen, C. Caron, A. Millaire, S. Marechaux, A.S. Polge, A. Vincentelli, F. Mouquet, P.V. Ennezat, N. Lamblin, P. de Groote, E. Van Belle, G. Deklunder, J. Goudemand, C. Bauters, and B. Jude Functional impairment of von Willebrand factor in hypertrophic cardiomyopathy: relation to rest and exercise obstruction Circulation 118 2008 1550 1557
16. T.E. Warkentin, J.C. Moore, S.S. Anand, E.M. Lonn, and D.G. Morgan Gastrointestinal bleeding, angiodysplasia, cardiovascular disease, and acquired von Willebrand syndrome Transfus Med Rev 17 2003 272 286
17. J.L. Blackshear, H.V. Schaff, S.R. Ommen, D. Chen, and W.L. Nichols Hypertrophic obstructive cardiomyopathy, bleeding history, and acquired von Willebrand syndrome: response to septal myectomy Mayo Clin Proc 86 2011 219 224
18. W.L. Nichols, M.B. Hultin, A.H. James, M.J. Manco-Johnson, R.R. Montgomery, T.L. Ortel, M.E. Rick, J.E. Sadler, M. Weinstein, and B.P. Yawn von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA) Haemophilia 14 2008 171 232
19. M.A. Hlatky, R.E. Boineau, M.B. Higginbotham, K.L. Lee, D.B. Mark, R.M. Califf, F.R. Cobb, and D.B. Pryor A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index) Am J Cardiol 64 1989 651 654
20. H. Baumgartner, J. Hung, J. Bermejo, J.B. Chambers, A. Evangelista, B.P. Griffin, B. Iung, C.M. Otto, P.A. Pellikka, M. Quinones, and American Society of Echocardiography; European Association of Echocardiography Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice J Am Soc Echocardiogr 22 2009 1 23
21. D. Chen, J.I. Tange, B.J. Meyers, R.K. Pruthi, W.L. Nichols, and J.A. Heit Validation of an automated latex particle-enhanced immunoturbidimetric von Willebrand factor activity assay J Thromb Haemost 9 2011 1993 2002
22. R.K. Pruthi, T.M. Daniels, J.A. Heit, D. Chen, W.G. Owen, and W.L. Nichols Plasma von Willebrand factor multimer quantitative analysis by in-gel immunostaining and infrared fluorescent imaging Thromb Res 126 2010 543 549
23. E.R. DeLong, D.M. DeLong, and D.L. Clarke-Pearson Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach Biometrics 44 1988 837 845
24. American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, R.O. Bonow, B.A. Carabello, C. Kanu, A.C. de Leon Jr., D.P. Faxon, M.D. Freed, W.H. Gaasch, B.W. Lytle, R.A. Nishimura, P.T. O'Gara, R.A. O'Rourke, C.M. Otto, P.M. Shah, J.S. Shanewise, S.C. Smith Jr., A.K. Jacobs, C.D. Adams, J.L. Anderson, E.M. Antman, D.P. Faxon, V. Fuster, J.L. Halperin, L.F. Hiratzka, S.A. Hunt, B.W. Lytle, R. Nishimura, R.L. Page, and B. Riegel ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons Circulation 114 2006 84 231
25. Z. Hachicha, J.G. Dumesnil, P. Bogaty, and P. Pibarot Paradoxical low-flow, low-gradient severe aortic stenosis despite preserved ejection fraction is associated with higher afterload and reduced survival Circulation 115 2007 2856 2864
26. W.A. Zoghbi Low-gradient "severe" aortic stenosis with normal systolic function: time to refine the guidelines? Circulation 123 2011 838 840
27. S. Crow, D. Chen, C. Milano, W. Thomas, L. Joyce, V. Piacentino III, R. Sharma, J. Wu, G. Arepally, D. Bowles, J. Rogers, and N. Villamizar-Ortiz Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients Ann Thorac Surg 90 2010 1263 1269
28. A.L. Meyer, D. Malehsa, C. Bara, U. Budde, M.S. Slaughter, A. Haverich, and M. Strueber Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device Circ Heart Fail 3 2010 675 681
29. W.L. Chandler, E.I. Peerschke, D.D. Castellone, P. Meijer, and NASCOLA Proficiency Testing Committee Von Willebrand factor assay proficiency testing: the North American Specialized Coagulation Laboratory Association experience Am J Clin Pathol 135 2011 862 869
30. A. Tiede, J. Priesack, S. Werwitzke, K. Bohlmann, B. Oortwijn, P. Lenting, R. Eisert, A. Ganser, and U. Budde Diagnostic workup of patients with acquired von Willebrand syndrome: a retrospective single-centre cohort study J Thromb Haemost 6 2008 569 576